Vaxfab Enterprises Limited (BOM:542803)
60.84
+0.84 (1.40%)
At close: Jul 17, 2026
Vaxfab Enterprises Revenue
In the fiscal year ending March 31, 2026, Vaxfab Enterprises had annual revenue of 1.31B INR with 123.73% growth. Vaxfab Enterprises had revenue of 459.88M in the quarter ending March 31, 2026, with 1,342.09% growth.
Revenue
1.31B
Revenue Growth
+123.73%
P/S Ratio
1.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 725.92M | 123.73% |
| Mar 31, 2025 | 586.71M | 495.27M | 541.64% |
| Mar 31, 2024 | 91.44M | -76.09M | -45.42% |
| Mar 31, 2023 | 167.53M | 164.01M | 4,663.41% |
| Mar 31, 2022 | 3.52M | -7.85M | -69.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paul Merchants | 20.74B |
| Tirupati Starch and Chemicals | 3.66B |
| Abate AS Industries | 1.59B |
| CHL Limited | 1.39B |
| Panchsheel Organics | 1.07B |
| Resonance Specialties | 902.48M |
| Aartech Solonics | 408.84M |
| Auro Laboratories | 307.40M |